Improving Outcomes for Patients With CML: The Latest on TKIs and Combination Treatment Approaches
Thank you for your interest in attending the Clinical Care Options’ (CCO) symposium, Improving Outcomes for Patients With CML: The Latest on TKIs and Combination Treatment Approaches, originally scheduled for June 13, 2020, in Frankfurt, Germany. Due to the global impact of COVID-19, EHA organizers have decided to host the 25th EHA Congress in a virtual format.
As such, this live symposium will now be held as virtual live Webinar. The Webinar will still feature the original expert faculty, interactivity, evidence-based content, and panel discussions. When participating in the live Webinar, you will be able to text questions directly to the faculty and the planned agenda allows time for the faculty to discuss and answer submitted questions.
If you’ve previously registered for the live symposium, your registration will be automatically converted to the live Webinar. No further action is needed; you will receive an email with a link to join in advance of the webinar.
We look forward to having you join us for this interactive, live Webinar. In addition, we invite to you visit our Web site to access the many available online hematology and oncology programs and clinical resources.
CCO Member Service
Attend this live Webinar to hear CML experts from the United States and Europe discuss the latest treatment advances with the use of tyrosine kinase inhibitors in patients with chronic myeloid leukemia.